Per-Particle Triglyceride-Rich Lipoproteins Imply Higher Myocardial Infarction Risk Than Low-Density Lipoproteins: Copenhagen General Population Study

Autor: George Davey Smith, Signe Vedel-Krogh, Sune F. Nielsen, Shoaib Afzal, Børge G. Nordestgaard, Mia Ø. Johansen
Rok vydání: 2021
Předmět:
Adult
Male
medicine.medical_specialty
Magnetic Resonance Spectroscopy
Time Factors
Denmark
Myocardial Infarction
030204 cardiovascular system & hematology
Lipoproteins
VLDL

Risk Assessment
lipids
03 medical and health sciences
chemistry.chemical_compound
Young Adult
0302 clinical medicine
Internal medicine
medicine
Low density
Humans
030212 general & internal medicine
Myocardial infarction
Particle Size
Stroke
Triglycerides
Aged
Dyslipidemias
Aged
80 and over

Triglyceride
business.industry
Middle Aged
medicine.disease
Prognosis
metabolomics
stroke
Lipoproteins
LDL

chemistry
Lipoproteins
IDL

Heart Disease Risk Factors
Apolipoprotein B-100
Cardiology
Population study
lipids (amino acids
peptides
and proteins)

epidemiology
Female
Cardiology and Cardiovascular Medicine
business
apolipoproteins
Biomarkers
Zdroj: Johansen, M Ø, Vedel-Krogh, S, Nielsen, S F, Afzal, S, Davey Smith, G & Nordestgaard, B G 2021, ' Per particle triglyceride-rich lipoproteins imply higher myocardial infarction risk than low-density lipoproteins : Copenhagen General Population Study ', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 41, no. 6, pp. 2063-2075 . https://doi.org/10.1161/ATVBAHA.120.315639
Johansen, M, Vedel-Krogh, S, Nielsen, S F, Afzal, S, Smith, G D & Nordestgaard, B G 2021, ' Per-particle triglyceride-rich lipoproteins imply higher myocardial infarction risk than low-density lipoproteins copenhagen general population study ', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 41, pp. 2063-2075 . https://doi.org/10.1161/ATVBAHA.120.315639
ISSN: 1524-4636
Popis: Objective: ApoB (Apolipoprotein B)-containing triglyceride-rich lipoproteins and LDL (low-density lipoproteins) are each causal for myocardial infarction and atherosclerotic cardiovascular disease; however, the relative importance is unknown. We tested the hypothesis that for the same number of nonfasting apoB-containing particles from smaller LDL through to larger triglyceride-rich lipoproteins, the risk of myocardial infarction is similar. Approach and Results: We included 29 039 individuals with no history of myocardial infarction nested within 109 751 individuals from the Copenhagen General Population Study. Particle number of apoB-containing lipoprotein subfractions were measured using nuclear magnetic resonance spectroscopy. During a mean follow-up of 10 years, 2309 individuals developed myocardial infarction. Multivariable-adjusted hazard ratios for myocardial infarction per 1×10 15 particles were higher with larger size and more triglyceride content of apoB-containing lipoproteins using ten different subfractions, ranging from 11 (95% CI, 5.6–22) for extra extra large VLDL (very-low-density lipoproteins) to 1.06 (1.05–1.07) for extra small VLDL to 1.02 (1.01–1.02) for IDL (intermediate-density lipoproteins), through to 1.01 (1.01–1.01) for small LDL. When combining the particle number of 6 VLDL subfractions and combining IDL and 3 LDL subfractions, hazard ratios for myocardial infarction per 1×10 17 particles were 3.5 (2.7–4.5) for VLDL and 1.3 (1.2–1.4) for IDL and LDL combined. Conclusions: For the same number of apoB-containing particles (1×10 17 particles/L), the hazard ratio for myocardial infarction was 3.5-fold for VLDL and 1.3-fold for IDL and LDL combined. Biological implications include that VLDL particles are more atherogenic than LDL particles and clinically that VLDL and LDL should be measured separately.
Databáze: OpenAIRE